These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16126897)

  • 21. Involvement of Rap-1 activation and early termination of immune synapse in CTLA-4-mediated negative signal.
    Hara S; Nakaseko C; Yamasaki S; Hattori M; Bos JL; Saito Y; Minato N; Saito T
    Hematology; 2009 Jun; 14(3):150-8. PubMed ID: 19490760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TCR subunit specificity of CTLA-4-mediated signaling.
    Siu E; Carreno BM; Madrenas J
    J Leukoc Biol; 2003 Dec; 74(6):1102-7. PubMed ID: 12972512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes.
    Hernandez-Caselles T; Rubio G; Campanero MR; del Pozo MA; Muro M; Sanchez-Madrid F; Aparicio P
    Eur J Immunol; 1993 Nov; 23(11):2799-806. PubMed ID: 8223855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
    Vanhove B; Laflamme G; Coulon F; Mougin M; Vusio P; Haspot F; Tiollier J; Soulillou JP
    Blood; 2003 Jul; 102(2):564-70. PubMed ID: 12649149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubc9 Binds to ADAP and Is Required for Rap1 Membrane Recruitment, Rac1 Activation, and Integrin-Mediated T Cell Adhesion.
    Xiong Y; Ye C; Yang N; Li M; Liu H
    J Immunol; 2017 Dec; 199(12):4142-4154. PubMed ID: 29127148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human inducible costimulator ligand expression and function.
    Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
    J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
    Braakman E; Goedegebuure PS; Vreugdenhil RJ; Segal DM; Shaw S; Bolhuis RL
    Int J Cancer; 1990 Sep; 46(3):475-80. PubMed ID: 1975566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-independent inhibition of T cells by CTLA-4.
    Chikuma S; Abbas AK; Bluestone JA
    J Immunol; 2005 Jul; 175(1):177-81. PubMed ID: 15972645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTLA-4 differentially regulates the immunological synapse in CD4 T cell subsets.
    Jackman RP; Balamuth F; Bottomly K
    J Immunol; 2007 May; 178(9):5543-51. PubMed ID: 17442936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.
    McCoy KD; Hermans IF; Fraser JH; Le Gros G; Ronchese F
    J Exp Med; 1999 Apr; 189(7):1157-62. PubMed ID: 10190907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
    Yi LA; Hajialiasgar S; Chuang E
    Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular determinants of inverse agonist activity of biologicals targeting CTLA-4.
    Teft WA; Madrenas J
    J Immunol; 2007 Sep; 179(6):3631-7. PubMed ID: 17785798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses.
    Katagiri K; Hattori M; Minato N; Kinashi T
    Mol Cell Biol; 2002 Feb; 22(4):1001-15. PubMed ID: 11809793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1- and alpha5beta1-mediated function.
    Porter JC; Hogg N
    J Cell Biol; 1997 Sep; 138(6):1437-47. PubMed ID: 9298996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
    Chen W; Jin W; Wahl SM
    J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rap1-mediated lymphocyte function-associated antigen-1 activation by the T cell antigen receptor is dependent on phospholipase C-gamma1.
    Katagiri K; Shimonaka M; Kinashi T
    J Biol Chem; 2004 Mar; 279(12):11875-81. PubMed ID: 14702343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
    Fallarino F; Fields PE; Gajewski TF
    J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.